Virgilijus Uloza

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Ejection Fraction

Prognostic Factors

Squamous Cell Carcinoma

Top Venues

Discover. Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Agne Pasvenskaite, Rasa Liutkeviciene, Greta Gedvilaite, Alvita Vilkevičiūtė, Vykintas Liutkevicius, Virgilijus Uloza
The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms. Discover. Oncology 14 (1) (2023)
Agne Pasvenskaite, Rasa Liutkeviciene, Greta Gedvilaite, Alvita Vilkevičiūtė, Vykintas Liutkevicius, Virgilijus Uloza
The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms. Discover. Oncology 14 (1) (2023)
Agne Pasvenskaite, Rasa Liutkeviciene, Greta Gedvilaite, Alvita Vilkevičiūtė, Vykintas Liutkevicius, Virgilijus Uloza
The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms. Discover. Oncology 14 (1) (2023)
Agne Pasvenskaite, Rasa Liutkeviciene, Greta Gedvilaite, Alvita Vilkevičiūtė, Vykintas Liutkevicius, Virgilijus Uloza
The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms. Discover. Oncology 14 (1) (2023)